Quick Answer
Incannex Healthcare Inc. reported Total Revenue of $12.0 thousand for fiscal year 2024.
Incannex Healthcare Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | $12.0K | — | — | — | — |
| Net Income | -$46.88M -154.0% |
-$18.46M +62.2% |
-$48.81M | — | — | — |
| Diluted EPS | -$1.35 -17.4% |
-$1.15 +65.4% |
-$3.32 | — | — | — |
| Total Assets | $20.45M +19.9% |
$17.05M -28.3% |
$23.78M -37.2% |
$37.88M +306.1% |
$9.33M +120.2% |
$4.24M |
| Cash and Equivalents | $15.04M +156.7% |
$5.86M -73.5% |
$22.12M | — | — | — |
| Stockholders Equity | $13.39M +19.4% |
$11.22M -46.1% |
$20.82M -15.7% |
$24.71M | — | — |
| R&D Expense | $10.75M -16.6% |
$12.88M +104.1% |
$6.31M +17.4% |
$5.37M +13.1% |
$4.75M +125.0% |
$2.11M |
| Operating Income | -$23.79M +20.8% |
-$30.04M +39.5% |
-$49.67M | — | — | — |
| Shares Outstanding | 194.38M +1001.8% |
17.64M +11.1% |
15.87M | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2024 | $12.0K | — | -83.8% |
| Net Income | December 31, 2025 | -$6.52M | -10.6% | -1.8% |
| Diluted EPS | December 31, 2025 | -$0.02 | +93.9% | +0.0% |
| Total Assets | December 31, 2025 | $75.01M | +575.4% | -4.7% |
| Cash and Equivalents | December 31, 2025 | $68.90M | +3184.1% | -6.0% |
| Long-Term Debt | December 31, 2024 | $2.38M | — | — |
| Stockholders Equity | December 31, 2025 | $73.41M | +7514.7% | -4.7% |
| R&D Expense | December 31, 2025 | $2.28M | +61.2% | +103.6% |
| Operating Income | December 31, 2025 | -$7.00M | -39.8% | -3.0% |
| Shares Outstanding | December 31, 2025 | 359.22M | +1919.8% | +3.3% |
- Incannex Healthcare Inc. reported Total Revenue of $12.0 thousand for fiscal year 2024.
- Incannex Healthcare Inc. reported Net Income of -$46.88 million for fiscal year 2025.
- Incannex Healthcare Inc. showed a decrease of -154.0% in Net Income compared to the prior fiscal year.
- Incannex Healthcare Inc. reported Diluted EPS of $1.35 per share (loss) for fiscal year 2025.
- Incannex Healthcare Inc. showed a decrease of -17.4% in Diluted EPS compared to the prior fiscal year.
- Incannex Healthcare Inc. reported Total Assets of $20.45 million for fiscal year 2025.
- Incannex Healthcare Inc. showed an increase of +19.9% in Total Assets compared to the prior fiscal year.
- Incannex Healthcare Inc. reported Cash and Equivalents of $15.04 million for fiscal year 2025.
- Incannex Healthcare Inc. showed an increase of +156.7% in Cash and Equivalents compared to the prior fiscal year.
- Incannex Healthcare Inc. reported Stockholders Equity of $13.39 million for fiscal year 2025.
- Incannex Healthcare Inc. showed an increase of +19.4% in Stockholders Equity compared to the prior fiscal year.
- Incannex Healthcare Inc. reported R&D Expense of $10.75 million for fiscal year 2025.
- Incannex Healthcare Inc. showed a decrease of -16.6% in R&D Expense compared to the prior fiscal year.
- Incannex Healthcare Inc. reported Operating Income of -$23.79 million for fiscal year 2025.
- Incannex Healthcare Inc. showed an increase of +20.8% in Operating Income compared to the prior fiscal year.
- Incannex Healthcare Inc. reported Shares Outstanding of 194.38 million shares for fiscal year 2025.
- Incannex Healthcare Inc. showed an increase of +1001.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: